Changes in how healthcare is managed have had a meaningful effect on what contraceptive options are available to women.
Articles on Health insurance
Displaying 1 - 20 of 172 articles
A ‘no gap’ private health arrangement sounds great, but you may not be able to choose your specialist. Here’s what else you need to know.
A better deal on your private health insurance may be just a phone call away. What have you got to lose?
Medicaid enrollment surged during the pandemic, then tumbled during the Great Unwinding – reflecting how paperwork and state policy determine who keeps health coverage.
Whether a young person has public or private insurance – or is uninsured or underinsured – significantly influences their risk of death across many cancer types.
If you had your appendix out recently, does your insurer need to know? Different rules apply depending on the type of insurance. Here’s what you need to know.
If the government wants to pursue more public-private partnerships, it must consider a funding model that guarantees equity of access.
The US health insurance system requires that people make strategic and often risky decisions about how much health insurance they can afford and how much coverage they might need.
Scaling back Florida’s AIDS Drug Assistance Program could mean a resurgence of HIV/AIDS and increased health care costs throughout the state.
The government has allowed private health insurers to raise premiums by an average of 4.41% from April. How are these set? And why is it higher than inflation?
To lower health care costs, the Trump administration will have to wrangle a complex system fraught with competing interests.
The pilot, launched in January 2026 in 6 states, could reduce wasteful spending, but increases provider paperwork and risks patient access to necessary care.
When reputable local news outlets close, fewer people vote and get involved in local politics, and misinformation, corruption and polarization increase.
Why does health care reform keep failing despite decades of attention and expanding costs? A scholar of Congress has some answers.
US health care policy will remain fractured until lawmakers address the core question of who is responsible for health care costs.
While hospital CEO salaries and health insurance premiums have increased, health care quality has not.
Millions of Americans rely on this network of federally funded health clinics for their primary care.
Instead of treating creative work as a legitimate field, US labor policy, copyright law and the tax code have failed to offer artists stability or protection.
Florida relies on marketplace plans far more heavily than any other state. If subsidies are eliminated, health insurance will be unaffordable for many Floridians.
Short-term renewals of policies such as the ACA subsidies set up repeated battles in Congress.
Top contributors
-
Associate Professor of Public Health, The Ohio State University
-
Associate Professor of Health Law, Policy and Management, Boston University
-
Professor of Health Finance, Weatherhead School of Management & School of Medicine, Case Western Reserve University
-
Assistant Professor of Social, Behavioral and Population Sciences, Tulane University
-
Professor of Health Economics, The University of Melbourne
-
Research scientist of Health Policy and Economics, University of Southern California
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Research Scientist and Director of Research Training in Health Policy and Economics, University of Southern California
-
Assistant Professor of Health Policy and Management, UMass Amherst
-
Professor, Department of Health Policy, London School of Economics and Political Science
-
Senior Research Fellow and Lecturer of Gerontology, UMass Boston
-
Dean of the Sol Price School of Public Policy; Distinguished Professor of Pharmacy, Public Policy, and Economics, University of Southern California
-
Quintiles Professor of Pharmaceutical Development and Regulatory Innovation, Schaeffer Center for Health Policy and Economics, University of Southern California
-
Assistant Professor of Health Policy and Managment, School of Public Health, Texas A&M University